TY  - RPRT
TI  - Decoding primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma: The myeloid frontier.
AU  - Josepmaria Argemi
AU  - Claudia Campani
PY  - 2026
DO  - 10.1016/j.jhep.2026.08.004
UR  - https://pubmed.ncbi.nlm.nih.gov/42595139/
ID  - 42595139
ER  -